Skip to main navigation
Maze Therapeutics logo
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Governance
    • governance overview
    • leadership & board
    • committees & compositions
  • SEC Filings
  • Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Investor Contacts

Maze Therapeutics

SEC filing details

Document Details

Form
8-K
Filing Date
August 11, 2026
Document Date
Aug 11, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Maze Therapeutics
Issuer
MAZE THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Maze footer logo
We are committed to developing breakthrough precision medicines for common diseases with large unmet medical needs.
Further Together.
Impact Obsessed.
Stand True.
  • Privacy Notice
  • Terms of Use
  • Contact Us
  • X logo
  • LinkedIn logo